Atlas Venture Associates XII LLC 13D and 13G filings for Aerovate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-05 4:38 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | Atlas Venture Associates XII LLC | 88,682 12.700% | 88,682 (New Position) | Filing |